Using gene editing to boost the production of SOD3 in the choroid plexus reduced oxidative damage to brain tissue and cerebral spinal fluid in mice exposed to methotrexate.
Sufferers of obstructive sleep apnea are at increased risk of developing cancer and thrombosis. In those over 74, OSA was associated with an increased risk of cognitive decline.
Researchers have uncovered the molecular mechanisms behind cognitive deficits and brain fog associated with chemotherapy, and identified a current FDA-approved drug for multiple sclerosis that can help reduce chemotherapy-induced cognitive impairments.
Exposure to chemicals such as melamine, cyanuric acid, and aromatic amines from household products, hair dyes, and pesticides can cause cancer and lead to child developmental issues, researchers report. The study found the majority of pregnant women have levels of the toxic chemicals in urine samples.
Neurofeedback has the potential to alleviate symptoms of "brain fog" and cognitive impairments associated with chemotherapy.
In response to treatment, high-grade gliomas remodel the surrounding brain environment, creating interactions with nearby neurons and immune cells in ways that protect tumor cells and protect them from the body's natural defense.
Researchers found a positive correlation between glioblastoma cell proliferation and lactate metabolic indicators. Based on this observation, the researchers developed a biomimetic formulation using targeted delivery agents for lactate metabolism-based synergistic therapy against glioblastoma brain cancer.